Why the study?
Do Lipoprotein lipase (LPL) gene polymorphisms increase the risk of ischaemic stroke or carotid stenosis?
Do Lipoprotein lipase (LPL) gene polymorphisms increase the risk of ischaemic stroke or carotid stenosis?
LPL gene polymorphisms do not appear to significantly contribute to the overall risk of ischaemic stroke in the general population.
Answers are grounded in this paper and cite their sources.
LPL polymorphisms show no stroke or stenosis association in case-control data; leaves open subgroup or interaction effects.
Ischaemic stroke is pathogenetically heterogeneous, but there is strong evidence that genetic as well as environment factors contribute to the risk of the individual. Here we report the similar distribution of polymorphic markers of the lipoprotein lipase (LPL) gene in 128 patients with ischaemic stroke, 56 patients with carotid artery stenosis and 95 healthy control subjects, in spite of a significant influence of the Asn291-->Ser mutation on serum levels of triglycerides. We conclude that these LPL polymorphisms do not contribute greatly to the overall risk of ischaemic stroke in the general population.
No takes yet. Share an insight, caveat, or question.
Huang et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: